Nano-microcapsules containing docosahexaenoic acid, preparation method and application thereof, and animal feed or food

CN118697009BActive Publication Date: 2024-12-03INNER MONGOLIA YILI IND GROUP CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411188665.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-28
Publication Date
2024-12-03
Estimated Expiration
2044-08-28

AI Technical Summary

Technical Problem

During the digestion process of ruminants, docosahexaenoic acid (DHA) is prone to hydrogenation and instability, resulting in a high loss rate, limiting its enrichment and application in milk.

Method used

Using pH-responsive materials and nanocoating technology, nano-containing nano microcapsules are prepared. The core material contains DHA algae oil, emulsifiers and antioxidants. The core material contains zein and gastric wall material contains chitosan or Polyacrylic resin forms nano-microcapsules with particle size less than 400 nm, and is prepared by high-speed shear, ultrasonic and spray drying processes.

Benefits of technology

Effectively prevent the degradation of DHA in the rumen, ensure release in the true stomach and small intestine, improve the utilization rate of DHA in ruminants, and the nano microcapsules have excellent overrumen performance and stability, which are suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118697009B_ABST
    Figure CN118697009B_ABST
Patent Text Reader

Abstract

The present invention provides a nano-microcapsule containing docosahexaenoic acid, a preparation method and application thereof, and animal feed or food, wherein the nano-microcapsule comprises a core material, a core-coating wall material, and a gastric-soluble wall material from the inside to the outside, the core material comprises DHA algae oil, an emulsifier, and an antioxidant, the core-coating wall material comprises zein, and the gastric-soluble wall material comprises chitosan or polyacrylic acid resin IV; wherein the weight ratio of DHA algae oil, zein, and chitosan or polyacrylic acid resin IV is 1:5-10:5-10. The nano-microcapsule containing docosahexaenoic acid provided by the present invention has excellent rumen-passing performance and stability, and can be accurately released / responsively released in an acidic (low pH value) environment such as the abomasum and small intestine, so as to facilitate absorption by the abomasum and small intestine.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a nanometer microcapsule containing docosahexaenoic acid, a preparation method and application thereof, and animal feed or food, belonging to the technical field of animal feed additives or food additives. Background Art

[0002] Docosahexaenoic acid (DHA) is an essential ω-3 polyunsaturated fatty acid for humans. It has extremely high nutritional value and can participate in many important physiological processes of the human body. DHA is synthesized in very small amounts in the human body and needs to be supplemented through diet. Among many sources, cow's milk has unique advantages and is an important carrier for supplementing DHA. By adding DHA to the feed and utilizing the metabolic mechanism of dairy cows, DHA is enriched in cow's milk to form an organic whole, forming native DHA milk, which can effectively avoid the disadvantages of directly adding DHA to milk. Improving the nutritional value and quality of milk through biofortification is an important direction for solving the problems of the DHA milk industry. However, the special physiological structure of ruminants greatly limits the development of native DHA milk. Unsaturated fatty acids such as DHA are easily hydrogenated and unstable in the special digestive environment of the rumen, which greatly affects the enrichment of DHA in milk. It is reported that in the digestion and absorption process of ruminants, rumen digestion is the digestive link with the highest DHA loss rate. The loss rate of DHA in the rumen can reach more than 80%, which seriously limits the application of unsaturated fatty acids such as DHA in ruminants. Therefore, the development of unsaturated fatty acid rumen bypass products has become a research hotspot in recent years.

[0003] Ruminants have four stomachs, namely the rumen, reticulum, omasum and abomasum. The rumen is the main place where DHA is unstable, and its pH value is generally around 6.8, while the pH value of the abomasum (abomasum) is generally lower than 1.5, and it has a large amount of pepsin. Therefore, it is a very promising approach to use the difference between the physiological environment of the rumen and the abomasum, small intestine, etc. to specifically construct a rumen-passing carrier to reduce the loss of DHA. Summary of the invention

[0004] In order to solve the above shortcomings and deficiencies, the purpose of the present invention is to provide a nano-microcapsule containing docosahexaenoic acid, a preparation method and application thereof, and an animal feed or food. The present invention uses pH-responsive materials and nano-encapsulation technology to encapsulate or embed substances such as DHA, and the obtained nano-microcapsule can better prevent rumen degradation and can be well released in the abomasum and small intestine, thereby improving the utilization rate of DHA by ruminants.

[0005] In order to achieve the above objectives, on the one hand, the present invention provides a nano-microcapsule containing docosahexaenoic acid, wherein the nano-microcapsule comprises a core material, a core-coating wall material and a gastro-soluble wall material from the inside to the outside, the core material comprises DHA algae oil, an emulsifier and an antioxidant, the core-coating wall material comprises an amphiphilic protein such as zein, and the gastro-soluble wall material comprises a pH-responsive material such as chitosan or polyacrylic acid resin IV; wherein the weight ratio of DHA algae oil, zein and chitosan or polyacrylic acid resin IV is 1:5-10:5-10.

[0006] As a specific embodiment of the nano-microcapsules described above in the present invention, the weight ratio of the DHA algae oil, the emulsifier and the antioxidant is 100:1-2:1-2.

[0007] As a specific embodiment of the nano-microcapsules described above in the present invention, the emulsifier includes Tween 80 and the like, and the antioxidant includes tea polyphenols and the like.

[0008] As a specific embodiment of the nano-microcapsule described above of the present invention, the gastric-soluble wall material is chitosan.

[0009] As a specific embodiment of the nano-microcapsules described above in the present invention, the particle size of the nano-microcapsules containing docosahexaenoic acid is less than 400 nm.

[0010] On the other hand, the present invention also provides a method for preparing the above-mentioned nano-microcapsules containing docosahexaenoic acid, wherein the preparation method comprises:

[0011] S1: dissolving zein in an ethanol-water solution and mixing the mixture to obtain a zein solution;

[0012] S2: dissolving chitosan or polyacrylic acid resin IV in an acetic acid aqueous solution and mixing them to obtain a gastric soluble wall material solution;

[0013] S3: adding DHA algae oil, emulsifier and antioxidant into zein solution, and then forming nano-scale microcapsules by high-speed shearing, homogenization and ultrasound;

[0014] S4: slowly dripping the material obtained in S3 into the gastric soluble wall material solution and mixing evenly;

[0015] S5: vacuum drying the material obtained in S4 to remove ethanol and then centrifuging or filtering to obtain an emulsion;

[0016] S6: spray drying the emulsion to obtain the nano-microcapsules containing docosahexaenoic acid.

[0017] As a specific embodiment of the preparation method described above of the present invention, in S1, the volume concentration of ethanol in the ethanol-water solution is 75-85%, wherein the volume concentration is calculated based on the total volume of the ethanol-water solution.

[0018] As a specific embodiment of the preparation method described above of the present invention, in S1, the concentration of zein in the zein solution is 10-40 mg / mL, wherein the concentration is calculated based on the total volume of the zein solution.

[0019] As a specific embodiment of the preparation method described above of the present invention, in S2, the volume concentration of acetic acid in the acetic acid aqueous solution is 0.5-1%, wherein the volume concentration is calculated based on the total volume of the acetic acid aqueous solution.

[0020] As a specific embodiment of the preparation method described above of the present invention, in S2, the mass concentration of chitosan or polyacrylic acid resin IV in the gastric soluble wall material solution is 2-10 mg / mL, wherein the mass concentration is calculated based on the total volume of the gastric soluble wall material solution.

[0021] In S1 and S2 of the above preparation method of the present invention, mixing and homogenizing can be achieved by stirring.

[0022] As a specific embodiment of the preparation method described above, in S3, forming nano-scale microcapsules by high-speed shearing, homogenization and ultrasound includes:

[0023] First, high-speed shearing is performed at a speed of 8000-12000 r / min for 3-8 min, and then ultrasonication is performed for 5-15 min, wherein the ultrasonic frequency is 20-60 kHz and the power is 240-500 W; preferably, high-speed shearing is performed at a speed of 10000 r / min for 5 min, and then ultrasonication is performed for 10 min, wherein the ultrasonic frequency is 40 kHz and the power is 240 W.

[0024] In S4 of the preparation method described above, the mixing and homogenizing can also be achieved by stirring. In some embodiments of the present invention, the material obtained in S3 can be slowly dripped into the gastric wall material solution while the solution is stirred at high speed to achieve material mixing and homogenizing. In some embodiments of the present invention, the stirring speed in S4 can be 500-2000 r / min, preferably 1000 r / min, and the stirring time can be 20-40 min.

[0025] In S5 of the above preparation method of the present invention, the purpose of centrifugation or filtration is to filter out unstable particles to obtain an emulsion.

[0026] As a specific embodiment of the preparation method described above of the present invention, in S5, the vacuum drying may be rotary vacuum drying, and the vacuum drying time may be 15-30 min.

[0027] As a specific embodiment of the preparation method described above of the present invention, in S5, the centrifugal speed is 1500-2500 g, and the centrifugal time is 5-15 min, preferably 10 min.

[0028] As a specific embodiment of the above preparation method of the present invention, in S6, the inlet air temperature of the spray drying is 160-190°C, and the outlet air temperature is 75-85°C.

[0029] In another aspect, the present invention also provides the use of the above-mentioned nano-microcapsules containing docosahexaenoic acid as food additives or animal feed additives.

[0030] In another aspect, the present invention further provides an animal feed, comprising an animal feed additive, wherein the animal feed additive is the above-mentioned nano-microcapsules containing docosahexaenoic acid.

[0031] In the last aspect, the present invention further provides a food comprising a food additive, wherein the food additive is the above-mentioned nano-microcapsule containing docosahexaenoic acid.

[0032] Compared with the prior art, the beneficial technical effects that the present invention can achieve include:

[0033] The nano-microcapsules containing docosahexaenoic acid provided by the present invention have excellent rumen-passing performance and stability, and can be accurately released / responsively released in an acidic (low pH) environment such as the abomasum and small intestine, thereby facilitating absorption by the abomasum and small intestine.

[0034] The present invention adopts liquid lipids such as high-purity DHA algae oil to prepare the core material of the nano-microcapsule. The prepared nano-microcapsule has a small particle size (particle size is less than 400 nanometers) and a high bioaccessibility rate, which is convenient for the efficient conversion of DHA.

[0035] The nanometer microcapsules containing docosahexaenoic acid provided by the invention have reasonable composition and proportion, and the nanometer microcapsules have good granulation properties.

[0036] The preparation method of the nano-microcapsules containing docosahexaenoic acid provided by the present invention is simple and controllable, has low energy consumption, is conducive to safe production, has a short production cycle, and is suitable for large-scale production; in addition, the preparation method provided by the present invention is also suitable for the embedding of a variety of drugs or additives that need to be rumen-soluble and have similar properties to DHA, such as EPA. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the description of the embodiments will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0038] Figure 1 The figure is a process flow chart for preparing nano-microcapsules containing docosahexaenoic acid in an embodiment of the present invention. DETAILED DESCRIPTION

[0039] It should be noted that the term "comprises" and any variations thereof in the specification and claims of the present invention and the above-mentioned drawings are intended to cover non-exclusive inclusions. For example, a process, method, system, product or device that includes a series of steps or units is not necessarily limited to those steps or units clearly listed, but may include other steps or units that are not clearly listed or inherent to these processes, methods, products or devices.

[0040] "Scope" disclosed in the present invention is given in the form of lower limit and upper limit. It can be one or more lower limits, and one or more upper limits respectively. A given range is defined by selecting a lower limit and an upper limit. The selected lower limit and upper limit define the boundaries of a particular range. All ranges defined in this way are combinable, i.e. any lower limit can be combined with any upper limit to form a range. For example, for a specific parameter, a range of 60-120 and 80-110 is listed, and it is understood that a range of 60-110 and 80-120 is also expected. In addition, if the minimum range values ​​listed are 1 and 2, and the maximum range values ​​listed are 3, 4 and 5, then the following ranges can all be expected: 1-3, 1-4, 1-5, 2-3, 2-4 and 2-5.

[0041] In the present invention, unless otherwise specified, the numerical range "ab" represents an abbreviation of any real number combination between a and b, where a and b are real numbers. For example, the numerical range "0-5" means that all real numbers between "0-5" have been listed in the present invention, and "0-5" is just an abbreviation of these numerical combinations.

[0042] In the present invention, unless otherwise specified, all embodiments and preferred embodiments mentioned in the present invention can be combined with each other to form a new technical solution.

[0043] In the present invention, unless otherwise specified, all technical features and preferred features mentioned in the present invention can be combined with each other to form a new technical solution.

[0044] In the present invention, unless otherwise specified, all steps mentioned herein may be performed sequentially or randomly, but are preferably performed sequentially. For example, the method includes steps (a) and (b), which means that the method may include steps (a) and (b) performed sequentially, or may include steps (b) and (a) performed sequentially. For example, the method may further include step (c), which means that step (c) may be added to the method in any order, for example, the method may include steps (a), (b) and (c), or may include steps (a), (c) and (b), or may include steps (c), (a) and (b), etc.

[0045] In order to make the purpose, technical scheme and advantages of the present invention clearer, the present invention is further described in detail below in conjunction with the attached table, drawings and examples. The following described embodiments are some embodiments of the present invention, rather than all embodiments, and are only used to illustrate the present invention, and should not be regarded as limiting the scope of the present invention. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the field without making creative work are within the scope of protection of the present invention. If the specific conditions are not specified in the embodiments, they are carried out according to the normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified in the reagents or instruments used, they are all conventional products that can be purchased commercially. Example 1

[0046] This embodiment provides a nano-microcapsule containing docosahexaenoic acid, such as Figure 1 As shown, the preparation method thereof comprises:

[0047] S1: 8 g of zein was added to an ethanol-water solution with a volume concentration of 80%, and the mixture was stirred to make the zein concentration 20 mg / mL to obtain a zein solution;

[0048] S2: Select chitosan as the wall material: dissolve 8 g of chitosan in an acetic acid aqueous solution with a volume concentration of 1%, stir and mix to keep the chitosan concentration at 2 mg / mL, and obtain a gastric soluble wall material solution;

[0049] S3: 1.6 g of high-purity DHA algae oil (DHA weight content of 69.2%), 16 mg of tea polyphenols and 16 mg of Tween 80 were sequentially added to the zein solution obtained in S1, so that the concentrations of DHA algae oil, tea polyphenols and Tween 80 were 4 mg / mL, 0.04 mg / mL and 0.04 mg / mL respectively, and high-speed shearing was first performed at 10000 r / min for 5 min, and then ultrasonicated for 10 min to form nano-scale microcapsules. The nanoemulsion containing nano-scale microcapsules was obtained in this step;

[0050] S4: slowly dripping the material obtained in S3 into the gastric soluble wall material solution obtained in S2, while dripping the material, stirring the solution at high speed to mix the material, and continuing to stir and hydrate for 30 minutes after the mixing is completed, wherein the stirring speed is 1000 r / min;

[0051] S5: The material obtained in S4 was dried under a rotary vacuum at 40 °C for 30 min to remove ethanol, and then centrifuged at 2000 g for 10 min to filter out unstable particles to obtain an emulsion;

[0052] S6: spray drying the emulsion obtained in S5, wherein the air inlet temperature of the spray drying is 180° C. and the air outlet temperature is 80° C., and nano-microcapsules containing docosahexaenoic acid are collected and obtained. Example 2

[0053] This embodiment provides a nano-microcapsule containing docosahexaenoic acid, which is different from the embodiment 1 only in that the dosage of zein and chitosan is different. In this embodiment, the dosage of both is 16 g. Example 3

[0054] This embodiment provides a nano-microcapsule containing docosahexaenoic acid, which is different from the embodiment 1 only in that the amounts of zein and chitosan used are different. In this embodiment, the amounts of the two are 16 g and 8 g, respectively.

[0055] Comparative Example 1

[0056] This comparative example provides an unprotected high-purity DHA algae oil, wherein the DHA weight content is 69.2%.

[0057] Comparative Example 2

[0058] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is different from Example 1 only in that chitosan is not used and the amount of zein used is 3.2 g.

[0059] Comparative Example 3

[0060] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is different from Example 1 only in that chitosan is not used and the amount of zein used is 8 g.

[0061] Comparative Example 4

[0062] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is different from Example 1 only in that chitosan is not used and the amount of zein used is 16 g.

[0063] Comparative Example 5

[0064] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is prepared by a preparation method comprising the following specific steps:

[0065] Step (1): dissolving 8 g of chitosan in an aqueous solution of acetic acid having a volume concentration of 1%, stirring and mixing to keep the chitosan concentration at 2 mg / mL, to obtain a chitosan solution;

[0066] Step (2): 1.6 g of high-purity DHA algae oil (DHA weight content of 69.2%), 16 mg of tea polyphenols and 16 mg of Tween 80 are sequentially added to the chitosan solution obtained in step (1) to make the concentrations of DHA algae oil, tea polyphenols and Tween 80 4 mg / mL, 0.04 mg / mL and 0.04 mg / mL respectively, firstly high-speed shearing at 10000 r / min for 5 min, and then ultrasonicating for 10 min to form nano-scale microcapsules. In this step, a nanoemulsion containing nano-scale microcapsules is obtained;

[0067] Step (3): centrifuging the material obtained in step (2) at 2000 g for 10 min, filtering out unstable particles, and obtaining an emulsion;

[0068] Step (4): freeze-dry the emulsion obtained in step (3) to collect and obtain nano-microcapsules containing docosahexaenoic acid.

[0069] Comparative Example 6

[0070] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is prepared by a preparation method comprising the following specific steps:

[0071] Step (1): adding 8 g of zein to an ethanol-water solution with a volume concentration of 80%, stirring and mixing to make the zein concentration 20 mg / mL, to obtain a zein solution;

[0072] Step (2): dissolving 8 g of sodium carboxymethyl cellulose in an aqueous solution of acetic acid having a volume concentration of 1%, stirring and mixing to maintain the mass concentration of the sodium carboxymethyl cellulose at 2 mg / mL, to obtain a sodium carboxymethyl cellulose solution;

[0073] Step (3): 1.6 g of high-purity DHA algae oil (DHA weight content of 69.2%), 16 mg of tea polyphenols and 16 mg of Tween 80 are sequentially added to the zein solution obtained in S1, so that the concentrations of DHA algae oil, tea polyphenols and Tween 80 are 4 mg / mL, 0.04 mg / mL and 0.04 mg / mL respectively, and the mixture is first sheared at 10000 r / min for 5 min, and then ultrasonicated for 10 min to form nano-scale microcapsules. The nanoemulsion containing nano-scale microcapsules is obtained in this step;

[0074] Step (4): slowly dripping the material obtained in step (3) into the sodium carboxymethyl cellulose solution obtained in step (2) drop by drop, stirring the solution at high speed to mix the material, and continuing to stir and hydrate for 30 minutes after the mixing is completed, wherein the stirring speed is 1000 r / min;

[0075] Step (5): the material obtained in step (4) was subjected to rotary vacuum drying at 40°C for 30 min to remove ethanol, and then centrifuged at 2000 g for 10 min to filter out unstable particles to obtain an emulsion;

[0076] Step (6): freeze-drying the emulsion obtained in step (5). From the appearance of the obtained product, it can be seen that the product prepared by compounding sodium carboxymethyl cellulose and zein has poor cohesion and granulation properties and is easy to form a film.

[0077] Comparative Example 7

[0078] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is prepared by a preparation method comprising the following specific steps:

[0079] Step (1): 8 g of ethyl cellulose is added to an ethanol-water solution with a volume concentration of 80%, and stirred to mix well to make the concentration of ethyl cellulose 20 mg / mL, thereby obtaining an ethyl cellulose solution;

[0080] Step (2): dissolving 8 g of chitosan in an aqueous solution of acetic acid having a volume concentration of 1%, stirring and mixing to keep the mass concentration of chitosan at 2 mg / mL, to obtain a chitosan solution;

[0081] Step (3): 1.6 g of high-purity DHA algae oil (DHA weight content of 69.2%), 16 mg of tea polyphenols and 16 mg of Tween 80 are sequentially added to the zein solution obtained in S1, so that the concentrations of DHA algae oil, tea polyphenols and Tween 80 are 4 mg / mL, 0.04 mg / mL and 0.04 mg / mL respectively, and the mixture is first sheared at 10000 r / min for 5 min, and then ultrasonicated for 10 min to form nano-scale microcapsules. The nanoemulsion containing nano-scale microcapsules is obtained in this step;

[0082] Step (4): slowly dripping the material obtained in step (3) into the chitosan solution obtained in step (2) drop by drop, stirring the solution at high speed to mix the material, and continuing to stir and hydrate for 30 minutes after the mixing is completed, wherein the stirring speed is 1000 r / min;

[0083] Step (5): The material obtained in step (4) was subjected to rotary vacuum drying at 40°C for 30 min to remove ethanol, thereby obtaining an emulsion. The emulsion was unstable and prone to precipitation. From the appearance of the obtained product, it can be seen that the sample prepared by compounding ethyl cellulose and chitosan was unstable and prone to precipitation, and the product yield was low.

[0084] Comparative Example 8

[0085] This comparative example provides a nano-microcapsule containing docosahexaenoic acid, which is different from Example 1 only in that chitosan is not used, the amount of zein used is 8 g, and in S6, the emulsion obtained in S5 is freeze-dried.

[0086] From the product appearance of the nano-microcapsules containing docosahexaenoic acid provided in Comparative Examples 8 and 5, it can be seen that both zein and chitosan have good cohesion and granulation properties, and can spontaneously form particles with high-purity DHA algae oil. At the same time, according to the experimental data shown in Table 1 below, it can be seen that the rumen-passing efficiency of a single wall material is relatively low, and the rumen-passing effect of a composite material is higher.

[0087] Test Example 1

[0088] In this test example, the nanocapsules provided in Examples 1 to 3 of the present invention and Comparative Examples 1 to 4 were tested for in vitro rumen-passing performance to detect the rumen-passing efficiency of the nanocapsules. Three parallel samples were set for each sample. The specific steps are as follows:

[0089] An appropriate amount of nanocapsules and substrate (powder made by grinding daily cow feed) were placed in an anaerobic fermentation tube, and 15 mL of artificial simulated rumen fluid (the volume ratio of fresh rumen fluid: rumen simulated fluid was 1:2) was added into the anaerobic fermentation tube.

[0090] Among them, fresh rumen fluid is taken from the rumen of dairy cows, including:

[0091] 3 h after morning feeding, collect the rumen contents of the test cows equipped with rumen fistulas in a collection bottle and bring them back to the laboratory for processing within half an hour. Mix the rumen fluid evenly and filter it with four layers of gauze for later use.

[0092] The preparation method of rumen simulation fluid includes:

[0093] Prepare a trace element solution (Solution A) containing 1.32 g / L CaCl2·2H2O, 1.00 g / L MnCl2·4H2O, 0.10 g / L CoCl2·6H2O, and 0.80 g / L FeCl3·6H2O;

[0094] Prepare buffer solution (solution B) to contain 4 g / L NH4HCO3 and 35 g / L NaHCO3;

[0095] Prepare a major element solution (Solution C) containing 9.45 g / L Na2HPO4·12H2O, 6.2 g / L KH2PO4, and 0.6 g / L MgSO4·7H2O;

[0096] Prepare a reducing agent solution (Solution D) containing 95 mL of distilled water, 4 mL of 1 mol / L NaOH, 625 mg of NaS·9H2O, and 625 mg of L-cysteine ​​hydrochloride;

[0097] Preparation of rumen simulation fluid: add 0.1 mL of solution A, 208.1 mL of solution B, 208.1 mL of solution C and 520.2 mL of distilled water into a flask, and gently shake the flask to mix the solution thoroughly; place the flask in a microwave and continue to boil for about 10 min; place a magnetic bar into the flask and place it on a magnetic stirrer, maintain the temperature at 39 °C, continue to introduce CO2 gas for about 1 h, and adjust the pH value to 6.8; after adjustment, add 62.4 mL of solution D and mix well to obtain the rumen simulation fluid.

[0098] After artificial simulated rumen fluid and all substrates (appropriate amount of nano-microcapsules and powder made from grinding dairy cows' daily feed) were loaded into the anaerobic fermentation tube, carbon dioxide was introduced to fill the space inside the tube, and the tube was sealed and cultured in a 39 ℃ water bath shaker in the dark to simulate rumen digestion for 24 hours. In the first 12 hours, the tube was inverted and mixed at least once every hour, and in the next 12 hours, the tube was inverted and mixed every 3-4 hours to avoid flocculation of the test substance at the top, which would affect the experimental results. After 24 hours, the anaerobic fermentation tube was taken out, the DHA content was detected, and the DHA loss rate was calculated according to the following formula 1). The experimental data obtained are shown in Table 1 below.

[0099] DHA loss rate (%) = (C initial – C digesta ) / C initial × 100 (Formula 1);

[0100] In formula 1), C initial is the amount of DHA input before rumen digestion; C digesta It is the amount of DHA remaining after simulated digestion.

[0101] Table 1 DHA loss rate data of different nanocapsules after 24 h in vitro fermentation

[0102]

[0103] As can be seen from Table 1 above, after simulating 24 h of rumen digestion, the loss rate of unprotected DHA algae oil is as high as 68.18%. Compared with Comparative Example 1, the DHA loss rate of the zein-chitosan double-walled nano-microcapsules containing docosahexaenoic acid provided by Examples 1 to 3 of the present invention after 24 h of in vitro fermentation was greatly reduced, with the lowest loss rate being only 15.77%, which indicates that the zein-chitosan double-walled nano-microcapsules provided by the embodiments of the present invention effectively reduce the loss of DHA in the rumen, and the rumen passage rate of DHA in DHA algae oil is increased by 164.71%.

[0104] It can also be seen from Table 1 above that the DHA loss rate of the nano-microcapsules provided by Comparative Examples 2 to 4 after 24 h of in vitro fermentation is lower than that of Comparative Example 1, but is still significantly higher than that of the zein-chitosan double-wall nano-microcapsules containing docosahexaenoic acid provided by Examples 1 to 3 of the present invention, which indicates that the rumen-passing efficiency of the single-wall nano-microcapsules containing docosahexaenoic acid is higher than that of the unprotected DHA algae oil, but is still significantly lower than that of the composite-wall nano-microcapsules containing docosahexaenoic acid.

[0105] Test Example 2

[0106] This test example uses artificial simulated rumen fluid and artificial gastric fluid to simulate the release of the nano-microcapsules provided in Example 1 of the present invention in the abomasum, including: core material

[0107] 150 mg of the nanocapsules provided in Example 1 were placed in an anaerobic fermentation tube, 15 mL of artificial simulated rumen fluid (the same as in Test Example 1) was added to the anaerobic fermentation tube to dissolve the nanocapsules in the artificial simulated rumen fluid, carbon dioxide was introduced to fill the space inside the tube, the tube was sealed, and cultured in a 39°C water bath shaker in the dark to simulate rumen digestion for 12 h.

[0108] The fermentation tube was taken out, pepsin (purchased from McLean Biotech, P816236) was added to make its concentration 8.5 mg / mL, and then 2 mol / L hydrochloric acid was added to adjust the pH value to below 2 (this is equivalent to using artificial gastric juice for simulation), sealed, and cultured in a 39°C water bath shaker in the dark for 1 h.

[0109] Comparing the dissolution of the nanocapsules in artificial simulated rumen fluid and artificial gastric fluid, it can be seen that in the neutral environment of the rumen, the carrier wall material has poor solubility, the carrier of the nanocapsule provided in Example 1 of the present invention is not easy to collapse and disintegrate, and DHA will not be released; while in the acidic environment of the abomasum, the wall material of its carrier dissolves rapidly, releasing DHA for the next step of digestion. That is, the nanocapsule provided in Example 1 of the present invention can maintain good stability in the rumen environment and does not dissolve in the rumen environment, while its water solubility is enhanced in the simulated abomasum environment, and the core material is effectively released.

[0110] From the above experimental results, it can be seen that the wall materials of the nano-microcapsules containing docosahexaenoic acid provided in the embodiments of the present invention are zein and chitosan. The combination of zein and chitosan has good processability and stability, and is easy to form particles. Moreover, after the combination of the two, the rumen-passing efficiency of the nano-microcapsules containing docosahexaenoic acid is effectively improved, which proves that the two materials have a good synergistic effect.

[0111] The above is only a specific embodiment of the present invention, and cannot be used to limit the scope of the invention. Therefore, the replacement of equivalent components, or equivalent changes and modifications made according to the protection scope of the patent of the present invention, should still fall within the scope of this patent. In addition, the technical features of the present invention can be freely combined with each other, with each other and with each other, and with each other.

Claims

1. A nano-microcapsule containing docosahexaenoic acid, It is characterized in that The nano-microcapsule comprises a core material, a core-coating wall material and a gastro-soluble wall material from the inside to the outside, wherein the core material comprises DHA algae oil, an emulsifier and an antioxidant, the core-coating wall material is zein, and the gastro-soluble wall material is chitosan; wherein the weight ratio of DHA algae oil, zein and chitosan is 1:5-10:5-10; The particle size of the nano-microcapsules containing docosahexaenoic acid is less than 400 nm.

2. The nanocapsule according to claim 1, It is characterized in that The weight ratio of the DHA algae oil, the emulsifier and the antioxidant is 100:1-2:1-2.

3. The nanocapsule according to claim 1 or 2, It is characterized in that The emulsifier includes Tween 80, and the antioxidant includes tea polyphenols.

4. A method for preparing nano-microcapsules containing docosahexaenoic acid according to any one of claims 1 to 3, It is characterized in that The preparation method comprises: S1: dissolving zein in an ethanol-water solution and mixing the mixture to obtain a zein solution; S2: dissolving chitosan in an acetic acid aqueous solution and mixing the mixture to obtain a gastric soluble wall material solution; S3: adding DHA algae oil, emulsifier and antioxidant into zein solution, and then forming nano-scale microcapsules by high-speed shearing, homogenization and ultrasound; S4: slowly dripping the material obtained in S3 into the gastric soluble wall material solution and mixing evenly; S5: vacuum drying the material obtained in S4 to remove ethanol and then centrifuging or filtering to obtain an emulsion; S6: spray drying the emulsion to obtain the nano-microcapsules containing docosahexaenoic acid.

5. The preparation method according to claim 4, It is characterized in that In S1, the concentration of zein in the zein solution is 10-40 mg / mL.

6. The preparation method according to claim 4, It is characterized in that In S2, the mass concentration of chitosan in the gastric soluble wall material solution is 2-10 mg / mL.

7. The preparation method according to claim 4, It is characterized in that In S3, forming nano-scale microcapsules by high-speed shearing, homogenization and ultrasound includes: First, high-speed shearing is performed at a speed of 8000-12000 r / min for 3-8 minutes, and then ultrasonication is performed for 5-15 minutes, wherein the ultrasonic frequency is 20-60 kHz and the power is 240-500 W.

8. The preparation method according to claim 4, It is characterized in that In S6, the inlet air temperature of the spray drying is 160-190°C, and the outlet air temperature is 75-85°C.

9. Use of the nano-microcapsules containing docosahexaenoic acid according to any one of claims 1 to 3 as food additives or animal feed additives.

10. An animal feed comprising an animal feed additive, It is characterized in that The animal feed additive is the nano-microcapsule containing docosahexaenoic acid according to any one of claims 1 to 3.

11. A food comprising a food additive, It is characterized in that The food additive is the nano-microcapsule containing docosahexaenoic acid as claimed in any one of claims 1 to 3.